Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

NCT00602706 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: sargramostim
DRUG: melphalan
PROCEDURE: autologous hematopoietic stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: samarium Sm 153 lexidronam pentasodium

Sponsor

Mayo Clinic

Collaborators

[object Object]